Fasting Blood Glucose and Lipid Profile Alterations following Twelve-Month Androgen Deprivation Therapy in Men with Prostate Cancer

Table 1

Pretreatment and one-year treatment values of FBG levels and lipid profiles.

Variables	Pretreatment; (mg/dL)	3-month ADT (mg/dL)	6-month ADT (mg/dL)	12-month ADT (mg/dL)	𝑃^{
FBG(mean±SD)	101±10	102±9	102±9	105±7	0.009
TC(mean±SD)	190±37	210±38	207±39	221±19	0.000
HDL(mean±SD)	40±8	44±8	35±6	34±6	0.000
LDL(mean±SD)	113±32	130±30	137±32	145±12	0.000
TG(median(min-max))	129 (55–207)	165 (56–215)	158 (69–199)	148 (88–196)	0.000

FBG: fasting blood glucose, TC: total cholesterol, HDL: high-density lipoprotein, LDL: low-density lipoprotein, TG: triglyceride, ^¶P values denote the significance of the difference between the pretreatment and 12-month ADT values, SD: standard deviation.